SCHEMBL22065285

SCHEMBL22065285

CNc1cc(C(=O)Nc2cccc(Cl)c2)ccc1C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 2/20 0.60
KCNK3 O14649 3/20 0.59
KCNK9 Q9NPC2 2/20 0.59
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
ADORA3 P0DMS8 1/20 0.56
ADORA2A P29274 1/20 0.56
ADORA2B P29275 1/20 0.56
ADORA1 P30542 1/20 0.56
LMNA P02545 1/20 0.56
PTBP1 P26599 1/20 0.56
CNR2 P34972 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
P4HTM Q9NXG6 1/20 0.54
MAOB P27338 1/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22065294 0.88 KCNK3 (0.58) BRAFKCNK3KCNK9NPC1RAB9A
SCHEMBL22065291 0.86 MEN1 (0.68) KCNK3KCNK9NPC1RAB9ALMNA
SCHEMBL22024688 0.86 CNR2 (0.55) BRAFKCNK3KCNK9NPC1RAB9A
SCHEMBL22025353 0.86 KCNK3 (0.55) BRAFKCNK3KCNK9NPC1RAB9A
SCHEMBL22065286 0.84 BRAF (0.60) BRAFKCNK3KCNK9NPC1RAB9A
SCHEMBL23092213 0.82 NPC1 (0.62) BRAFKCNK3KCNK9NPC1RAB9A
SCHEMBL11315847 0.82 KCNK3 (0.60) BRAFKCNK3KCNK9NPC1RAB9A
SCHEMBL22066261 0.82 MAPK14 (0.64) BRAFKCNK3LMNASMN1; SMN2KDM4E
SCHEMBL22065404 0.82 RXFP1 (0.68) KCNK3KCNK9NPC1RAB9ASMN1; SMN2
SCHEMBL17131157 0.81 MAPK14 (0.72) BRAFKCNK3KCNK9RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663293-A1 SUBSTITUTED PENTA- AND HEXA-HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, DRUG COMBINATION AND USE THEREOF Xiamen University (CN) 2020-06-10 EP disclosed